Navigation Links
Haemonetics Announces Launch of Faster Plasma Collection Protocol
Date:6/16/2008

BRAINTREE, Ma., June 16 /PRNewswire-FirstCall/ -- Haemonetics Corporation announced today at the annual meeting of the Plasma Protein Therapeutics Association the launch of a plasma collection software for its PCS(R)2 plasma collection system that reduces plasma donation time by 20%.

Stephen Swenson, General Manager of Global Plasma for Haemonetics, said, "This new software system, with its faster donation times, combined with our recently launched information technology platforms that automate center operations, are significant enhancements to our product offerings. These systems help our plasma customers to better leverage their plasma collection infrastructure by increasing donor throughput and also provide the donor with a more positive donation experience."

"As the global leader in blood management solutions, we are pleased to be continually strengthening our product suite with products, information technology platforms, and business services for blood collectors and hospitals to improve patient outcomes," he added.

The PCS2 software was 510(k) cleared by the U.S. Food and Drug Administration on May 28, 2008. The software can be used with existing PCS2 devices so no device replacement or additional operator training is required. The product will be launched in limited market release, with full market release expected by year end.

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals,
'/>"/>

SOURCE Haemonetics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Haemonetics and Octapharma AG Announce Plasma Collection Technology Contract
2. Haemonetics(R) Appoints Peter Allen as Chief Marketing Officer
3. Haemonetics Becomes Preferred Provider of Plasma Collection Products to Octapharma Europe
4. Haemonetics Announces New Subsidiary, Haemonetics Software Solutions
5. Meritage Pharma, Inc. Announces Company Formation and $22.5M Series A Financing
6. Angiotech announces market launch of Quill(TM) SRS MONODERM(TM)
7. Exelixis Announces June 19 Webcast of Presentation at the William Blair 28th Annual Growth Stock Conference
8. Villa St. Benedict Announces New Web Site
9. BioNeutral Announces a BREAKTHROUGH in the Fight Against Bioterrorism
10. Indevus Announces Management Changes
11. Chindex International, Inc. Announces Fiscal 2008 Year End and Fourth Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... -- Axovant Sciences Ltd. (NYSE:  AXON), a leading clinical-stage biopharmaceutical ... presentations at three investor conferences: , Wednesday, September ... in New York at the New ... PM at the BioCentury NewsMakers Conference in New ... Center , Thursday, September 17 at 9:30 AM at ...
(Date:9/2/2015)... ... September 02, 2015 , ... The wet form of macular ... anti-vascular endothelial growth factor agents given by injection into the eye. Dry macular ... scientific protocol for the many millions diagnosed with it. AMD usually starts in ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... botanical and plant-derived compounds. BCC Research reveals in its new report that ... this market defines the category and generates the most market demand. , ...
(Date:9/2/2015)... TEL-AVIV, Israel , September 2, 2015 /PRNewswire/ ... BLGTY, TASE: BOLT) ("BioLight" or the "Company"), a ... innovations in ophthalmology and cancer diagnostics, announced today ... treatment of glaucoma will be delivered at the ... of the European Society of Cataract & Refractive ...
Breaking Biology Technology:Axovant Sciences To Present At Upcoming Investor Conferences 2Axovant Sciences To Present At Upcoming Investor Conferences 3StemCell GeneticMed Announces That It Has Started Stem Cell Treatments for Age Related Dry Macular Degeneration (AMG) 2Plant-derived Compounds Poised to Assume Greater Role in Global Drug Markets, According to BCC Research 2Plant-derived Compounds Poised to Assume Greater Role in Global Drug Markets, According to BCC Research 3Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 3
... N.C. and ROCKVILLE, M.D., June 5 ,Laboratory ... LH ), one,of the world,s leading clinical ... Inc. (Nasdaq: VNDA ), a biopharmaceutical ... clinical-stage product,candidates for central nervous system disorders, ...
... Results of phase I/II study highlighted in oral presentation at ... ... Switzerland, June 5 At the 10th,International Conference on Malignant ... investigator-sponsored clinical trial of,Yttrium-90 Ibritumomab Tiuxetan (90Y-Zevalin) combined with the ...
... 4 Trubion Pharmaceuticals Inc.,(Nasdaq: TRBN ) ... vice president of research and development, is scheduled ... Biotechnology & Medical Technology,Conference on June 12 at ... at the,New York Palace Hotel in New York ...
Cached Biology Technology:LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests 2LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests 3LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests 4LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests 5Novel Investigational Regimen Combining Radiation Enhancing Agent With Ibritumomab Tiuxetan (Zevalin(R)) Produces High Rate of Complete Responses in Patients With Rituximab-Refractory Follicular Non-Hodgkin's Lymphoma 2Novel Investigational Regimen Combining Radiation Enhancing Agent With Ibritumomab Tiuxetan (Zevalin(R)) Produces High Rate of Complete Responses in Patients With Rituximab-Refractory Follicular Non-Hodgkin's Lymphoma 3Novel Investigational Regimen Combining Radiation Enhancing Agent With Ibritumomab Tiuxetan (Zevalin(R)) Produces High Rate of Complete Responses in Patients With Rituximab-Refractory Follicular Non-Hodgkin's Lymphoma 4Trubion Pharmaceuticals to Present at the 7th Annual Needham & Company Biotechnology & Medical Technology Conference 2
(Date:8/6/2015)... Aug. 6, 2015 Synaptics Inc. (NASDAQ: ... interface solutions, today announced collaboration with Microsoft on ... 10. Microsoft leveraged Synaptics, deep expertise in human ... Through stringent testing, Synaptics, advanced ... with Microsoft,s Precision TouchPad (PTP) specification empowering OEMs ...
(Date:8/4/2015)... DUBLIN , Aug. 04, 2015 /PRNewswire/ ... ( http://www.researchandmarkets.com/research/nvh7k2/digital_forensics ) has announced the addition ... Component (Hardware, Software, and Service), Sub-Segment (Computer ... Cloud Forensics), Tool Types, Service, Vertical and ... report to their offering. By ...
(Date:7/31/2015)... , 31 de julio de 2015 BGI llevará ... www.icg-10.org ) del 22 al 25 de octubre de ... La conferencia celebra su décimo aniversario este año. ... en una de las reuniones anuales más influyentes del ... una de las conferencias científicas más dinámicas, entusiastas y ...
Breaking Biology News(10 mins):Synaptics Chosen for Human Interface Co-Development on Windows 10 2Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3
... the human gut adaptively shifts more than a quarter ... diet changes from sugar to complex carbohydrates. , This ... survive rapidly changing nutrient conditions but also helps maintain ... microbial society, according to researchers at Washington University School ...
... Inc. (Nasdaq: NGEN), developer of advanced diagnostic products, announced ... "Multiplexed Active Biologic Array" by the U.S. Patent and ... of addressing one or more electrodes (or "test sites") ... patent also covers a method for storing the value ...
... owners because of their vibrant colors. But those colors may ... For more than a century, biochemists have known that parrots ... of plumage colors, but their biochemical identity has remained elusive. ... behind the colors of parrots, describing on a molecular level ...
Cached Biology News:Highly adaptable genome in gut bacterium key to intestinal health 2Highly adaptable genome in gut bacterium key to intestinal health 3Nanogen Issued Patent for Electronic Microarray With Memory 2Transport System Smuggles Medicines Into Brain 2Transport System Smuggles Medicines Into Brain 3
... provides high-pressure tubing for use with ... chromatography systems. The kit includes precut ... PEEK tubing for the installation of ... running at flow rates less than ...
... 96 x 0.2 ml tubes or a ... a thumbwheel to adjust height and pressure ... cycling. Peltier heat pumps produce uniform, accurate ... of up to 1.4 degrees C per ...
... thermocycler provides maximum performance on minimum space. ... elements, high heating and cooling rates have ... times. With a maximum capacity of 48 ... the capacity of much more expensive 96 ...
Dual-bay Dyad thermal cycler chassis, does not include the Alpha units (requires 2)...
Biology Products: